Tarsus Pharmaceuticals, Inc. Common Stock (NASDAQ: TARS) last traded at $72.70, up 1.69% on the session. The quote above updates while this page is open; the figures below are drawn from Tarsus Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Tarsus Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker TARS. Its market capitalisation is $3.19 billion.
Valuation measures for Tarsus Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.19B |
|---|---|
| Enterprise value | $3.25B |
| Price / sales | 5.26 |
| Price / book | 9.20 |
| Beta | 0.57 |
Trailing-twelve-month figures tagged in Tarsus Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $606.33M |
|---|---|
| Net income (TTM) | -$46.48M |
| EPS (TTM) | -$1.06 |
| Operating margin | -8.00% |
| Return on equity | -13.40% |
| Cash | $204.59M |
Range and volume for TARS over the past 52 weeks.
| 52-week high | $85.25 |
|---|---|
| 52-week low | $48.20 |
| Volume | 570.0K |
| Average volume | 954.3K |
| Previous close | $71.49 |
Dividend history for Tarsus Pharmaceuticals, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.